No Data
No Data
Q BioMed Inc. Provides Update to Shareholders
NEW YORK, June 23, 2023 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides
Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Up 24.6% in February
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 37,500 shares,
Q BioMed Chemotherapy Uttroside B for Liver Cancer to Get US Patent
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent From United States Patent Office
Uttroside B Has Shown Promising Results in Initial Pre-Clinical Testing NEW YORK, Feb. 10, 2023 /PRNewswire/ -- Q BioMed Inc. (OTCQB:QBIO) a biotech acceleration and commercial stage company focused on licensing and
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Expands By 21.2%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant growth in short interest in the month of December. As of December 30th, there was short interest totalling 189,900 shares,
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Increases By 2,468.9%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 156,700 shares, a gr
No Data